TRML logo

Tourmaline Bio, Inc. (TRML) Cash From Investing

Annual CFI:

-$194.31M-$198.15M(-5160.03%)
December 31, 2024

Summary

  • As of today, TRML annual cash from investing is -$194.31 million, with the most recent change of -$198.15 million (-5160.03%) on December 31, 2024.
  • During the last 3 years, TRML annual cash from investing has fallen by -$97.92 million (-101.59%).
  • TRML annual cash from investing is now -5160.03% below its all-time high of $3.84 million, reached on December 31, 2023.

Performance

TRML Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLcash flow metrics

Quarterly CFI:

$16.30M-$9.64M(-37.15%)
June 30, 2025

Summary

  • As of today, TRML quarterly cash from investing is $16.30 million, with the most recent change of -$9.64 million (-37.15%) on June 30, 2025.
  • Over the past year, TRML quarterly cash from investing has increased by +$26.43 million (+260.92%).
  • TRML quarterly cash from investing is now -37.15% below its all-time high of $25.94 million, reached on March 31, 2025.

Performance

TRML Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLcash flow metrics

TTM CFI:

$46.94M+$26.43M(+128.91%)
June 30, 2025

Summary

  • As of today, TRML TTM cash from investing is $46.94 million, with the most recent change of +$26.43 million (+128.91%) on June 30, 2025.
  • Over the past year, TRML TTM cash from investing has increased by +$242.06 million (+124.06%).
  • TRML TTM cash from investing is now -0.93% below its all-time high of $47.38 million, reached on September 1, 2022.

Performance

TRML TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTRMLcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

TRML Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-5160.0%+260.9%+124.1%
3Y3 Years-101.6%-18.2%+9.8%
5Y5 Years-10000.0%+357.2%+262.2%

TRML Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-5160.0%at low-37.1%+108.6%-0.9%+122.7%
5Y5-Year-5160.0%at low-37.1%+108.6%-0.9%+121.7%
All-TimeAll-Time-5160.0%at low-37.1%+108.6%-0.9%+121.7%

TRML Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
$16.30M(-37.2%)
$46.94M(+128.9%)
Mar 2025
-
$25.94M(+58.3%)
$20.50M(+110.6%)
Dec 2024
-$194.31M(-5160.0%)
$16.39M(+240.1%)
-$194.31M(+6.0%)
Sep 2024
-
-$11.70M(-15.4%)
-$206.80M(-6.0%)
Jun 2024
-
-$10.13M(+94.6%)
-$195.12M(-5.5%)
Mar 2024
-
-$188.87M(-4950.3%)
-$185.00M(-4917.8%)
Dec 2023
$3.84M(+175.8%)
$3.89M(>+9900.0%)
$3.84M(+107.4%)
Sep 2023
-
-$17.00K(-30.8%)
-$51.78M(-13.9%)
Jun 2023
-
-$13.00K(+45.8%)
-$45.46M(-78.1%)
Mar 2023
-
-$24.00K(+100.0%)
-$25.52M(-403.5%)
Dec 2022
-$5.07M
-
-
Dec 2022
-
-$51.73M(-920.5%)
-$5.07M(-110.7%)
DateAnnualQuarterlyTTM
Sep 2022
-
$6.30M(-68.4%)
$47.38M(+10.8%)
Jun 2022
-
$19.93M(-2.4%)
$42.77M(+155.3%)
Mar 2022
-
$20.43M(+2733.1%)
-$77.29M(+19.8%)
Dec 2021
-$96.39M(+27.7%)
$721.00K(-57.4%)
-$96.39M(+52.2%)
Sep 2021
-
$1.69M(+101.7%)
-$201.47M(+6.8%)
Jun 2021
-
-$100.13M(-7628.7%)
-$216.21M(-92.2%)
Mar 2021
-
$1.33M(+101.3%)
-$112.52M(+15.6%)
Dec 2020
-$133.30M(>-9900.0%)
-$104.36M(-699.8%)
-$133.30M(-360.7%)
Sep 2020
-
-$13.05M(-465.9%)
-$28.94M(-82.1%)
Jun 2020
-
$3.57M(+118.3%)
-$15.89M(+18.3%)
Mar 2020
-
-$19.45M
-$19.45M
Dec 2019
-$562.00K
-
-

FAQ

  • What is Tourmaline Bio, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. annual cash from investing year-on-year change?
  • What is Tourmaline Bio, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. quarterly cash from investing year-on-year change?
  • What is Tourmaline Bio, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Tourmaline Bio, Inc.?
  • What is Tourmaline Bio, Inc. TTM cash from investing year-on-year change?

What is Tourmaline Bio, Inc. annual cash from investing?

The current annual cash from investing of TRML is -$194.31M

What is the all-time high annual cash from investing for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high annual cash from investing is $3.84M

What is Tourmaline Bio, Inc. annual cash from investing year-on-year change?

Over the past year, TRML annual cash from investing has changed by -$198.15M (-5160.03%)

What is Tourmaline Bio, Inc. quarterly cash from investing?

The current quarterly cash from investing of TRML is $16.30M

What is the all-time high quarterly cash from investing for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high quarterly cash from investing is $25.94M

What is Tourmaline Bio, Inc. quarterly cash from investing year-on-year change?

Over the past year, TRML quarterly cash from investing has changed by +$26.43M (+260.92%)

What is Tourmaline Bio, Inc. TTM cash from investing?

The current TTM cash from investing of TRML is $46.94M

What is the all-time high TTM cash from investing for Tourmaline Bio, Inc.?

Tourmaline Bio, Inc. all-time high TTM cash from investing is $47.38M

What is Tourmaline Bio, Inc. TTM cash from investing year-on-year change?

Over the past year, TRML TTM cash from investing has changed by +$242.06M (+124.06%)
On this page